Involvement of prohibitin 1 and prohibitin 2 upregulation in cBSA-induced podocyte cytotoxicity

Heng-Hsiung Wu1, Chao-Jung Chen2, Pei-Yu Lin3

  • 1Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.

Insights

Membranous nephropathy (MN) involves kidney damage. Researchers found prohibitin proteins (PHB1/PHB2) increase in MN, promoting kidney cell damage and proliferation, suggesting new diagnostic and treatment targets.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Proteomics

Background:

  • Membranous nephropathy (MN) is a leading cause of nephrotic syndrome in adults.
  • Effective treatments for MN are limited, necessitating the discovery of new diagnostic and therapeutic targets.

Purpose of the Study:

  • To identify novel protein targets for the diagnosis and treatment of membranous nephropathy.
  • To investigate the role of specific proteins in the pathogenesis of MN using a mouse model.

Main Methods:

  • Established a mouse model of MN via cationic bovine serum albumin (cBSA) administration.
  • Utilized label-free proteomics and immunohistochemistry (IHC) to analyze protein expression changes in kidney tissues.
  • Performed shRNA-mediated knockdown and microarray analysis to assess protein function and regulatory mechanisms.

Main Results:

  • Identified 273 differentially expressed proteins in MN mice, with downregulation in cellular catabolic processes.
  • Observed significant upregulation of prohibitin 1 (PHB1) and prohibitin 2 (PHB2) in kidney tubular cells and glomeruli of MN mice.
  • Demonstrated that PHB1/PHB2 knockdown inhibited p53, promoted podocyte proliferation, and contributed to cBSA-induced cytotoxicity, potentially linked to proteasome activity blockage.

Conclusions:

  • Upregulation of PHB1 and PHB2 is implicated in the pathogenesis of membranous nephropathy.
  • PHB2's role in cBSA-mediated podocyte cytotoxicity suggests it as a potential therapeutic target for MN.
  • Further research into proteasome activity and PHB proteins may yield new diagnostic and treatment strategies for MN.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.1K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.7K